DBG
CNCE

De Burlo Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

De Burlo Group’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$1.34K – 192
2022
Q3 		$1.34K Buy
+200
New +$1.34K ﹤0.01% 183
2022
Q2 		– Sell
-200
Closed -$674 – 205
2022
Q1 		$674 Buy
+200
New +$674 ﹤0.01% 168